Navigation Links
Brown-Harvard team solves mobile DNA's surgical sleight-of-hand

In a clever bit of biology called site-specific recombination, DNA can travel inside an organism, or into another organism, and perform a sort of grafting surgery that allows it to insert its chromosome into a chromosome of the target cell. The process is important because mobile DNA can carry genes that cause drug resistance or transmit viruses that cause disease or tumors that result in certain leukemias or other cancers.

But what do the surgeons look like that conduct these intricate snip-and-solder procedures?

While scientists have studied site-specific recombination for about 30 years, much remains a mystery. In the current issue of Nature, a Brown University and Harvard Medical School team reveals the crystal structure of λ-integrase (λ-INT), the protein responsible for this DNA doctoring in the lambda virus, which infects and lives off Escherichia coli (E. coli) bacteria.

The findings are important because lambda is a model virus used to understand mobile DNA, according to Arthur Landy, professor of medical science in the Department of Molecular Biology, Cell Biology and Biochemistry at Brown. "Once you see the parts and how they fit together, you have a much better understanding of how the process works," Landy said. "So this work represents a major leap."

When the lambda virus inserts its DNA into E. coli, λ-INT is the major player in the process, literally snipping the E. coli DNA strands before insertion and then sealing them up afterward. The research also suggests how three "helper" proteins ?think of them as nurses ?intricately fold the DNA strands during this surgery.

Marta Radman-Livaja, a postdoctoral research associate at Brown, conducted the biological and biochemical aspects of the experiments. The Harvard team ?Tapan Biswas, Hideki Aihara, David Filman and Tom Ellenberger ?used X-ray crystallography, a technique that combines strong X-rays and sophisticated computer software, to create a 3-D digital image o f λ-INT caught in the act of carrying out site-specific recombination.

In complementary experiments carried out at Brown and published recently in the Proceedings of the National Academy of Sciences, Radman-Livaja tagged bits of lambda DNA with dyes that allowed her to draw up a map of this viral DNA during insertion.

"It was gratifying to see that two totally different experimental approaches give the same picture," Radman-Livaja said. "It means we have a very solid foundation for the next step forward in understanding this fascinating process."


'"/>

Source:Brown University


Related biology news :

1. NASA study solves ocean plant mystery
2. Insight into DNAs weakest links may yield clues to cancer biology
3. Uncovering DNAs sweet secret
4. “Nano-scissors?laser shows precise surgical capability
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: